Please provide your email address to receive an email when new articles are posted on . The Optos California, an ultra-widefield retinal imaging system designed for the tabletop, is equipped with the ...
Please provide your email address to receive an email when new articles are posted on . Toku’s BioAge software will be integrated into ultra-widefield retinal imaging devices from Optos. BioAge can ...
UK-based retinal imaging company Optos, which sells a variety of optics-based systems for diagnosing eye diseases, has won a “UK PLC” award recognizing its technology development. Part-organized by ...
A Hattiesburg, Mississippi, eye doctor, Dr. David Richardson, first used Optos Optopmap retinal imaging camera last May to examine a picture of his own eye. What he saw, according to Hattiesburg ...
KINGWOOD, TX--(Marketwired - November 21, 2016) - This November Vision Source and Optos are proud to highlight innovative advancements in diabetic eye care in honor of National Diabetes Awareness ...
Optos, the Scottish eyecare specialist and rising technology star, yesterday said it had added a third device to its range, and that the new product was aimed at the needs of an important customer ...
The purpose of this report is to demonstrate that a non-contact ultra-widefield dual wavelength laser camera (Optos) is able to capture high-quality images in retinopathy of prematurity (ROP). We ...
LONDON (Alliance News) - Medical retinal imaging company Optos PLC Tuesday said the first shipments of its California ultra-widefield imaging platform product have started. "We have begun shipments of ...
"While Optos and Spectralis are comparable for measuring GA in clinical trials and patient monitoring, the two modalities are not interchangeable. Clinicians and researchers should stick to one ...
Opko says deal will help it concentrate on drug and diagnostic development for eye diseases. Opko Health is getting $17.5 million in cash for selling its ophthalmic instrumentation business to Optos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results